What We're Reading: Page 202
Industry reads hand-picked by our editors
Jul 08, 2020
-
The New York Times
‘It Will Consume Your Life’: 4 Families Take On Rare Diseases
-
POLITICO
The Dangerous Race for the Covid Vaccine
-
Evaluate Vantage
What pandemic? Biotech floats break records
-
BioCentury
FDA credibility on the line with White House pressure on hydroxychloroquine
Jul 07, 2020
-
The New York Times
The Fullest Look Yet at the Racial Inequity of Coronavirus
-
Reuters
Moderna spars with U.S. scientists over COVID-19 vaccine trials
-
FierceBiotech
Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold
-
STAT
Data show panic, disorganization dominate the study of Covid-19 drugs
Jul 06, 2020
-
The Wall Street Journal
Coronavirus Researchers Compete to Enroll Subjects for Vaccine Tests
-
Reuters
Make a vaccine? I'm trying to teach my kids the alphabet
-
STAT
Immunomedics' breast cancer drug delays tumor growth, prolongs survival
-
The Sunday Times
GlaxoSmithKline nears £500m UK coronavirus vaccine deal
Jul 02, 2020
Jul 01, 2020
-
Wired
The CEO of Novartis on Developing Drugs During a Pandemic
-
The New York Times
Why Surviving Covid Might Come Down to Which NYC Hospital Admits You
-
Reuters
From Parkinson's to peanut allergy, pandemic puts brakes on new drugs
-
ProPublica
She Needed Lifesaving Medication, but the Only Hospital in Town Did Not Have It
Jun 30, 2020
Jun 29, 2020
-
The New York Times
A ‘Cure for Heart Disease’? A Single Shot Succeeds in Monkeys
-
STAT
Pharma giants to unveil major $1 billion venture to push novel antibiotics
-
Reuters
CanSino's COVID-19 vaccine candidate approved for military use in China
-
Axios
Fauci on coronavirus vaccine: Herd immunity in U.S. "unlikely"
Previous
